TXNIP Regulates Peripheral Glucose Metabolism in Humans
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Type 2 diabetes mellitus (T2DM) is characterized by defects in insulin secretion and action. Impaired glucose uptake in skeletal muscle is believed to be one of the earliest features in the natural history of T2DM, although underlying mechanisms remain obscure. METHODS AND FINDINGS: We combined human insulin/glucose clamp physiological studies with genome-wide expression profiling to identify thioredoxin interacting protein (TXNIP) as a gene whose expression is powerfully suppressed by insulin yet stimulated by glucose. In healthy individuals, its expression was inversely correlated to total body measures of glucose uptake. Forced expression of TXNIP in cultured adipocytes significantly reduced glucose uptake, while silencing with RNA interference in adipocytes and in skeletal muscle enhanced glucose uptake, confirming that the gene product is also a regulator of glucose uptake. TXNIP expression is consistently elevated in the muscle of prediabetics and diabetics, although in a panel of 4,450 Scandinavian individuals, we found no evidence for association between common genetic variation in the TXNIP gene and T2DM. CONCLUSIONS: TXNIP regulates both insulin-dependent and insulin-independent pathways of glucose uptake in human skeletal muscle. Combined with recent studies that have implicated TXNIP in pancreatic beta-cell glucose toxicity, our data suggest that TXNIP might play a key role in defective glucose homeostasis preceding overt T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 TXNIP Expression in Individuals with Diabetes or at Risk for Developing Diabetes (A) TXNIP expression levels from individuals with NGT, IGT, or T2DM, using data from our previously published microarray study [18]. * p < 0.02; ** p < 0.01, Mann-Whitney U-test. (B) TXNIP expression levels from NGT individuals with family history of T2DM (FH+) or without (FH−), as well as individuals with T2DM, using data from a previously published microarray study [27]. * p < 0.03, Mann-Whitney U-test.](https://figures.cochat.ai/paper-figures/ca9ef16bc19d42259bbcc36f2b7c4340/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-2.jpg)

![Figure 4 Insulin-Mediated Glucose Uptake Versus TXNIP Expression This relationship is shown for individuals with NGT, IGT, and T2DM. Linear regression parameters are indicated for each of the groups. Data are from our previously published microarray study [18].](https://figures.cochat.ai/paper-figures/c969253506d74789b5b972b212cc68b2/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-4.jpg)

![Figure 6 Pattern of Genetic Variation at the TXNIP Locus Linkage disequilibrium between SNPs was analyzed using Haploview [55], and D′ values were calculated with 95% confidence intervals. D′ plot for each square depicts the magnitude of linkage disequilibrium for a pair of markers, red indicates high D′ with high logarithm of odds (LOD) score, while white indicates low D′ with low LOD score, and blue indicates high D′ with low LOD score.](https://figures.cochat.ai/paper-figures/1e45333953bb4d3999d14146d7c357ce/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-6.jpg)
![Figure 7 Model of TXNIP Regulation and Action and Its Potential Role in the Pathogenesis of T2DM (A) Previous studies have shown that glucose induces the expression of TXNIP in a variety of cells and tissues. In this study we show that insulin suppresses the expression of TXNIP. Moreover, we have found that forced expression of TXNIP results in reduced glucose uptake, while inhibition of TXNIP enhances glucose uptake. These results suggest that TXNIP serves as a glucose- and insulin-sensitive homeostatic switch that regulates glucose uptake in the periphery. (B) Role of TXNIP in glucose toxicity in the β-cell and in impaired glucose uptake in the periphery. Insulin deficiency or hyperglycemia can increase TXNIP levels in muscle, resulting in impaired peripheral glucose uptake. The pancreatic β-cell is initially able to compensate by secreting more insulin, but eventually the β-cell compensation fails. The resulting hyperglycemia may then elevate pancreatic β-cell TXNIP expression, which can induce apoptosis [40]. The loss of β-cells, in turn, results in decreased insulin production that further exacerbates peripheral IGT. The vicious cycle would eventually spiral to T2DM.](https://figures.cochat.ai/paper-figures/00021f5e308f4c0db15afac10c663543/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“TXNIP not only binds to and inhibits thioredoxin, but also antagonizes glucose uptake through a yet undefined mechanism (Parikh et al., 2007).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Parikh et al., 2007
In the citing paper
“TXNIP not only binds to and inhibits thioredoxin, but also antagonizes glucose uptake through a yet undefined mechanism (Parikh et al., 2007).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Parikh et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426 · cited 1×
“RNA Isolation, Target Preparation, and Hybridization RNA from skeletal muscle biopsies for studies A and B were extracted by the guadinium thiocyanate method [11].”
MethodHaploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525 · cited 1×
“Linkage disequilibrium between SNPs was analyzed using Haploview [55], and D9 values were calculated with 95% confidence intervals.”
MethodGolub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516 · cited 1×
“For study A, targets from human skeletal muscle biopsies [12] were hybridized to the Affymetrix HG-U133A GeneChip (http://www.”
MethodIn silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Self-citationBiochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K.-Y. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,764 · cited 1×
“To relate expression data with insulin-stimulated glucose uptake, a GEE model was used to adjust for the interdependence between twins [9,30].”
MethodBase-Calling of Automated Sequencer Traces Using Phred. I. Accuracy Assessment
Ewing, B., Hillier, L., Wendl, M. C., & Green, P. (1998) · Genome Research · doi:10.1101/gr.8.3.175 · Cited by 6,967 · cited 1×
“Each base was called using the PHRED software package [19,20], and quality scores were assigned.”
MethodBase-Calling of Automated Sequencer Traces Using Phred. II. Error Probabilities
Ewing, B., & Green, P. (1998) · Genome Research · doi:10.1101/gr.8.3.186 · Cited by 5,439 · cited 1×
“]. Genomic DNA was isolated from peripheral blood using standard procedures. We used specific primers (Applied Biosystems) to amplify the region by PCR. Sequencing was performed using Big Dye version 3.1 Cycle Sequencing kit (Applied Biosystems) according to the manufacturer's instructions, and separation was done on…”
MethodInfluential
Research works printed but not linked: 56
- Kahn, 1994, Diabetes, 43, 1066
- Eriksson, 1989, N Engl J Med, 321, 337
- Lyssenko, 2005, Diabetes, 54, 166
- Martin, 1992, Lancet, 340, 925
- Groop, 1996, Diabetes, 45, 1585
- Roden, 2005, Int J Obes, 2, S111
- Shulman, 2000, J Clin Invest, 106, 171
- Eriksson, 1990, Diabetologia, 33, 526
- Ling, 2004, J Clin Invest, 114, 1518
- Poulsen, 2005, Diabetes, 54, 275
- Chomczynski, 1987, Anal Biochem, 162, 156
- Golub, 1999, Science, 286, 531
- Wabitsch, 2001, Int J Obes Relat Metab Disord, 25, 8
- Al-Khalili, 2003, Cell Mol Life Sci, 60, 991
- Rubin, 1977, J Biol Chem, 252, 3554
- Al-Khalili, 2003, Biochem Biophys Res Commun, 307, 127
- Yoshioka, 2004, Circulation, 109, 2581
- Mootha, 2003, Nat Genet, 34, 267
- Ewing, 1998, Genome Res, 8, 186
- Ewing, 1998, Genome Res, 8, 175
- Staden, 1996, Mol Biotechnol, 5, 233
- de Bakker, 2005, Nat Genet, 37, 1217
- Florez, 2004, Diabetes, 53, 3313
- Purcell, 2003, Bioinformatics, 19, 149
- McClintick, 2006, BMC Bioinformatics, 7, 49
- Tusher, 2001, Proc Natl Acad Sci U S A, 98, 5116
- Patti, 2003, Proc Natl Acad Sci U S A, 100, 8466
- Yechoor, 2002, Proc Natl Acad Sci U S A, 99, 10587
- Yechoor, 2004, Proc Natl Acad Sci U S A, 101, 16525
- Zeger, 1986, Biometrics, 42, 121
- Zandbergen, 2005, Biochem J, 392, 313
- Phan, 2004, Nature, 432, 635
- Lee, 2003, Science, 302, 453
- Nishiyama, 1999, J Biol Chem, 274, 21645
- Shalev, 2002, Endocrinology, 143, 3695
- Hirota, 2002, J Biol Chem, 277, 44244
- Kobayashi, 2003, Kidney Int, 64, 1632
- Schulze, 2004, J Biol Chem, 279, 30369
- Hansen, 2004, Biochem Biophys Res Commun, 323, 685
- Minn, 2005, Endocrinology, 146, 2397
- Wolfrum, 2003, Proc Natl Acad Sci U S A, 100, 11624
- Elbein, 1999, Diabetes, 48, 1175
- Vionnet, 2000, Am J Hum Genet, 67, 1470
- Donnelly, 2004, J Nutr, 134, 1475
- Sheth, 2005, J Lipid Res, 46, 123
- Brownlee, 2001, Nature, 414, 813
- Houstis, 2006, Nature, 440, 944
- Petersen, 2003, Science, 300, 1140
- Wang, 2006, Oncogene, 25, 1903
- Han, 2003, Oncogene, 22, 4035
- DeFronzo, 2004, Med Clin North Am, 88
- Bonner-Weir, 2000, Trends Endocrinol Metab, 11, 375
- Poitout, 2002, Endocrinology, 143, 339
- Zierath, 2003, Best Pract Res Clin Endocrinol Metab, 17, 385
- Barrett, 2005, Bioinformatics, 21, 263
- Furuyama, 2000, Biochem J, 349, 629
Cited by
Items 301–400 of 499
Rong, J., Xu, X., Xiang, Y., Yang, G., Ming, X., He, S., Liang, B., Zhang, X., & Zheng, F. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15045 · Cited by 15
Nakamura, S., Yonekura, S., Shimosato, T., & Takaya, T. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.679152 · Cited by 15
“Sterol regulatory element-binding proteins (SREBF1 and SREBF2), fatty acid synthase (FASN), insulin receptor substrates (IRS1 and IRS2), glucose transporter 4 (SLC2A4), mitochondrial carnitine palmitoyltransferase 2 (CPT2), and thioredoxin interacting protein (TXNIP) are insulin resistance-related factors and involved…”
BackgroundOvarian transcriptome profile from pre-laying period to broody period of Xupu goose
Qin, H., Li, X., Wang, J., Sun, G., Mu, X., & Ji, R. (2021) · Poultry Science · doi:10.1016/j.psj.2021.101403 · Cited by 16
Txnip deficiency promotes β-cell proliferation in the HFD-induced obesity mouse model
Lei, Z., Chen, Y., Wang, J., Zhang, Y., Shi, W., Wang, X., Xing, D., Li, D., & Jiao, X. (2022) · Endocrine Connections · doi:10.1530/ec-21-0641 · Cited by 18
Pyroptosis and Insulin Resistance in Metabolic Organs
Wei, H., & Cui, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911638 · Cited by 20
“It is worth noting that the expression of TXNIP in skeletal muscle is regulated by insulin [72].”
BackgroundNieborak, A., Lukauskas, S., Capellades, J., Heyn, P. C., Santos, G. S. S., Motzler, K., Zeigerer, A., Bester, R., Protzer, U., Schelter, F., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101748 · Cited by 16
“TXNIP and its close homolog ARRDC4 have been implicated in regulation of glucose uptake [27,98].”
BackgroundRas Suppresses TXNIP Expression by Restricting Ribosome Translocation
Ye, Z., & Ayer, D. E. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00178-18 · Cited by 15
“Sin3A MG132 (h) 0 2 4 0 2 4 Vector Ras TXNIP(1-156)-dsLuc D”
BackgroundInfluentialHigh TXNIP expression accelerates the migration and invasion of the GDM placenta trophoblast
Sa, R., Ma, J., Yang, J., Li, D., Du, J., Jia, J. C., Li, Z. Y., Huang, N., Lamusi, A., Sha, R., et al. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05524-6 · Cited by 14
“Thus, TXNIP might play a regulatory role in maintaining intracellular glucose homeostasis [9, 10].”
BackgroundKawamoto, E., Tamakoshi, K., Ra, S., Masuda, H., & Kawanaka, K. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00951.2017 · Cited by 16
“Thioredoxin-interacting protein (TXNIP) was originally identified as a binding partner for thioredoxin (19) and was more recently found to be a key negative regulator of insulin signaling and glucose uptake (11, 20, 28).”
BackgroundInfluentialJoseph, S., Alava, B. R., Antolic, A. T., Richards, E. M., Wood, C. E., & KELLER-WOOD, M. E. (2020) · Physiological Genomics · doi:10.1152/physiolgenomics.00096.2019 · Cited by 15
“TXNIP, an important regulator of glucose and fatty acid metabolism in tissues including the skeletal muscles, is upregulated by glucose and suppressed by insulin, often being elevated in the muscles of prediabetics and diabetics (43).”
BackgroundNoura, M., Matsuo, H., Koyama, A., Adachi, S., & Masutani, H. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12908 · Cited by 14
Buyandelger, U., Walker, D. G., Taguchi, H., Yanagisawa, D., & Tooyama, I. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.08.114 · Cited by 14
The Role of Mondo Family Transcription Factors in Nutrient-Sensing and Obesity
Ke, H., Luan, Y., Wu, S., Zhu, Y., & Tong, X. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.653972 · Cited by 15
“In response to glucose and fructose, MondoA activates transcription of thioredoxin interacting protein (TXNIP) and arrestin domaincontaining 4 (ARRDC4), which inhibits glucose uptake (Figure 3) (56, 61).”
BackgroundMalayeri, A., Zakerkish, M., Ramesh, F., Galehdari, H., Hemmati, A. A., & Angali, K. A. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01145-4 · Cited by 14
“expression is increased under hyperglycemic conditions [4, 14, 18].”
BackgroundTsai, H., Shen, C., Ho, C., Hsu, S., Tantoh, D. M., Nfor, O. N., Chiu, S., Chou, Y., & Liaw, Y. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03269-y · Cited by 14
“Furthermore, its overexpression in cultured adipocytes was associated with inhibited glucose uptake and vice versa [18].”
BackgroundInfluentialEndocytic regulation of alkali metal transport proteins in mammals, yeast and plants
Mulet, J. M., Llopis-Torregrosa, V., Primo, C., Marqués, M. C., & Yenush, L. (2013) · Current Genetics · doi:10.1007/s00294-013-0401-2 · Cited by 16
“This data is in good agreement with previous studies showing that TXNIP is a potent inhibitor of glucose uptake (Parikh et al. 2007; Patwari et al. 2009).”
ResultJee, C., Choi, T.-W., Kalichamy, K., Yee, J. Z., Song, H., Ji, Y. J., Lee, J., Lee, J. I., L’Étoile, N. D., Ahnn, J., et al. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.01.012 · Cited by 15
“CNP-1 is α-arrestin containing two arrestin motifs and shows moderate homology to human ARRDC2–4 [ARRDC (arrestindomain-containing protein)] and the thioredoxininteracting protein (TXNIP), which binds to inhibit thioredoxin and is implicated in hypoglycemia and hyperlipidemia in mammals.(6,7) cnp-1 deletion mutants sh…”
Posttranslational regulation of thioredoxin-interacting protein
Robinson, K. A., Brock, J. W. C., & Buse, M. G. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0091 · Cited by 19
Bazile, J., Jaffrézic, F., Déhais, P., Reichstadt, M., Klopp, C., Laloë, D., & Bonnet, M. (2020) · Physiological Genomics · doi:10.1152/physiolgenomics.00020.2020 · Cited by 14
“The gene TXNIP encodes the thioredoxin (cid:2) interacting protein that has been shown to regulate both insulin-dependent and insulin-independent pathways of glucose uptake in human skeletal muscle (45).”
BackgroundGüneş, A., İşcan, E., Topel, H., Avcı, S. T., Gümüştekin, M., Erdal, E., & Atabey, N. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.05.025 · Cited by 14
A role for thioredoxin-interacting protein (Txnip) in cellular creatine homeostasis
Zervou, S., Ray, T., Sahgal, N., Sebag‐Montefiore, L., Cross, R., Medway, D. J., Ostrowski, P. J., Neubauer, S., & Lygate, C. A. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00637.2012 · Cited by 14
“There are interesting parallels with our current study in that Txnip is upregulated by high glucose in diabetic tissues (28, 33) and has been shown to regulate both insulin-dependent and -independent pathways of glucose uptake (28).”
MondoA senses adenine nucleotides: transcriptional induction of thioredoxin-interacting protein
Han, K.-S., & Ayer, D. E. (2013) · Biochemical Journal · doi:10.1042/bj20121126 · Cited by 14
Presnell, S. R., Spear, H. K., Durham, J., Riddle, T., Applegate, A., & Lutz, C. T. (2020) · ImmunoHorizons · doi:10.4049/immunohorizons.2000065 · Cited by 14
Mitigation of nicotine-induced podocyte injury through inhibition of thioredoxin interacting protein
Datta, S., Rahman, M. A., Koka, S., & Boini, K. M. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118110 · Cited by 19
Complex Disease Interventions from a Network Model for Type 2 Diabetes
Rende, D., Baysal, N., & Kırdar, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065854 · Cited by 13
“[36–39].”
Early Predictors in the Onset of Type 2 Diabetes at Different Fasting Blood Glucose Levels
Xie, X., Bai, G., Liu, H., Zhang, L., He, Y., Qiang, D., & Zou, X. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s301352 · Cited by 13
“TXNIP can mediate oxidative stress through physiological or pathological inhibition of TRX expression and can also directly activate the inflammatory process, inhibit glucose uptake and participate in the development of insulin resistance, diabetes, and other diseases.(5,27,28,34,35) Studies in isolated human islet ce…”
BackgroundBrandão, L. E. M., Espes, D., Westholm, J. O., Martikainen, T., Westerlund, N., Lampola, L., Popa, A., Vogel, H., Schürmann, A., Dickson, S. L., et al. (2021) · Journal of Sleep Research · doi:10.1111/jsr.13472 · Cited by 16
“Given that FGF21 is also tied to tissue-specific regulation of insulin sensitivity, we explored a biomarker of cellular stress that is specifically thought to be involved in tissue insulin sensitivity, i.e. thioredoxin-interacting protein ( TXNIP ; Parikh et al., 2007).”
BackgroundResultInfluentialTXNIP loss expands Myc-dependent transcriptional programs by increasing Myc genomic binding
Lim, T.-Y., Wilde, B. R., Thomas, M. L., Murphy, K. E., Vahrenkamp, J. M., Conway, M. E., Varley, K. E., Gertz, J., & Ayer, D. E. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3001778 · Cited by 13
“This study and others demonstrate and establish that TXNIP is a repressor of at least 2 common features of the transformed state: Myc transcriptional activity and glucose uptake [1,5,55,56].”
BackgroundShi, S., Pan, X., Chen, M., Zhang, L., Zhang, S., Wang, X., Shi, S., Chen, Z., Lin, W., & Jiang, Y. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000193 · Cited by 18
Wang, M., Cai, X., LIANG, R., Zhang, E.-M., Liang, X.-Q., Liang, H., Fu, C. L., Zhou, A.-D., Shi, Y. Y., Xu, F. L., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115515 · Cited by 14
Li, T., Lin, G., Li, Z., Zhou, Y., Wang, J., Zhu, Y., Yang, F., Cai, X., Liu, Q., Nosjean, O., et al. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.15 · Cited by 13
Davis, R., Murgia, C., Dordevic, A. L., Bonham, M. P., & Huggins, C. E. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.01.011 · Cited by 13
Lekva, T., Bollerslev, J., Sahraoui, A., Scholz, H., Bøyum, H., Evang, J. A., Godang, K., Aukrust, P., & Ueland, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064247 · Cited by 14
“The positive association between TXNIP from bone and insulin levels is in contrast to the reciprocal relationship in healthy individuals reported by Parikh et al [21] and the interaction between TXNIP and insulin may thus differ between these groups of individuals as well as tissues investigated (i.e. bone, skeletal m…”
BackgroundResultInfluentialWang, L., Curran, G. L., Zhong, R., Xue, Z., Veerareddy, V., Thieschafer, J. S., Min, H.-K. P., Li, L., Lowe, V. J., & Kandimalla, K. K. (2025) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x251332493 · Cited by 14
“57,81 It was further reported that TXNIP binds to GLUT1 and facilitates its endocytosis through clathrin-coated pits.”
Hirata, C. L., Ito, S., & Masutani, H. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.108159 · Cited by 12
Maeda, K., Yamada, H., Munetsuna, E., Fujii, R., Yamazaki, M., Ando, Y., Mizuno, G., Ishikawa, H., Ohashi, K., Tsuboi, Y., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235486 · Cited by 12
“β-cell function and glucose homeostasis [4].”
BackgroundBaufeld, A., Koczan, D., & Vanselow, J. (2019) · BMC Genomics · doi:10.1186/s12864-019-5657-6 · Cited by 12
New Insight into Metformin Mechanism of Action and Clinical Application
Yan, Y., Kover, K. L., & Moore, W. V. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91148 · Cited by 13
Lappalainen, Z., Lappalainen, J., Laaksonen, D. E., Oksala, N., Khanna, S., Sen, C. K., & Atalay, M. (2010) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.20.3.206 · Cited by 12
Popescu, R. G., Dinischiotu, A., Soare, T., Vlase, E., & Marinescu, G. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052594 · Cited by 13
Ling, C., Vaváková, M., Mir, B. A., Säll, J., Perfilyev, A., Martin, M., Jansson, P., Davegårdh, C., Asplund, O., Hansson, O., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03789-y · Cited by 11
“1B), including MTHFD1 and TXNIP , the latter was previously shown to be upregulated in skeletal muscle from subjects with prediabetes and T2D and it was inversely correlated with glucose uptake [29].”
Self-citationShi, C., Yuan, F., Chen, X., Xu, S., Ding, Y., Wen, H., Duan, C., Wu, T., Lu, H., Hu, J., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104078 · Cited by 12
“TXNIP is a master regulator of energy metabolism, and its expression is modulated by glucose, amino acids, and insulin [46,47]; however, no study has determined whether lactate, the end product of glycolysis, can induce the expression of TXNIP.”
VDUP1 exacerbates bacteremic shock in mice infected with Pseudomonas aeruginosa
Piao, Z.-H., Kim, M. S., Jeong, M., Yun, S., Lee, S. H., Sun, H., Song, H. Y., Suh, H., Jung, H., Yoon, S. R., et al. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.11.003 · Cited by 11
“VDUP1 is a stress response protein associated with diverse cellular functions, and its expression significantly increases in various cell types under stress conditions [19,35–38].”
BackgroundLam, Y. T., Tan, R. P., Michael, P. L., Yang, N., Dunn, L., Cooke, J. P., Celermajer, D. S., Wise, S. G., & Ng, M. (2022) · Microvascular Research · doi:10.1016/j.mvr.2022.104396 · Cited by 11
Ran, H., Lu, Y., Zhang, Q., Hu, Q., Zhao, J., Wang, K., Tong, X., & Su, Q. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0212 · Cited by 11
“org MondoA, inhibits glucose uptake [9,19].”
FoxO6-Mediated TXNIP Induces Lipid Accumulation in the Liver through NLRP3 Inflammasome Activation
Kim, M. E., Lee, J. S., Kim, T. W., Park, M. H., & Kim, D. H. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2023.1826 · Cited by 10
“Numerous cell types, including adipocytes, endothelial cells, pancreatic β-cells, and skeletal myocytes, express TXNIP, and TXNIP functions as an endogenous inhibitor of thioredoxin, a protein that scavenges reactive oxygen species [20,21].”
Sun, Y., Pan, Z., Wang, Z., Wang, H., Wei, L., Cui, F., Zou, Q., & Zhang, Z. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05706-6 · Cited by 12
Dawes, K., Philibert, W., Darbro, B. W., Simons, R. L., & Philibert, R. A. (2022) · Genes · doi:10.3390/genes13040683 · Cited by 10
“For example, TXNIP has been shown to be induced by glucose and overexpressed in diabetic patients [23].”
BackgroundVerapamil and Its Role in Diabetes
Zimmermann, P., Aberer, F., Eckstein, M. L., Haupt, S., Erlmann, M. P., & Moser, O. (2022) · Diabetology · doi:10.3390/diabetology3030030 · Cited by 13
“Next to the mentioned positive effects of orally administrated verapamil on the β-cell preservation and the improved glycemic control [31,48], several overall beneficial effects”
BackgroundInfluentialMuhammad, S. N. H., Safuwan, N. A. M., Yaacob, N. S., & Fauzi, A. N. (2023) · Pharmaceuticals · doi:10.3390/ph16020153 · Cited by 11
“TXNIP is another regulator for GLUT1 plasma membrane localization [55].”
BackgroundChen, F., Chai, Y.-H., Zhang, F., Liu, Y.-Q., Zhang, Y., Shi, Y.-J., Zhang, J.-M., & Leng, Y. (2023) · Bioscience Reports · doi:10.1042/bsr20230539 · Cited by 10
“However, TXNIP is involved in glucose metabolism and transport, and inhibition of TXNIP induces cell cycle arrest and drives apoptotic events and the consequent potential tumor risk are the main issues in targeting TXNIP applications [45].”
Altahla, R., & Xu, T. (2024) · Metabolites · doi:10.3390/metabo14090488 · Cited by 10
“While TXNIP is often upregulated in diseases such as diabetes [8], cardiovascular disorders [9], and neurodegenerative conditions [10,11], it tends to be downregulated in certain types of cancer [12].”
BackgroundThioredoxin-Interacting Protein (TXNIP) in Gestational Diabetes Mellitus
Kokkinopoulou, I., & Papadopoulou, A. (2025) · Metabolites · doi:10.3390/metabo15060351 · Cited by 10
“The link between hyperglycemia and TXNIP in diabetes has been extensively documented in pancreatic beta cells and in insulin target tissues, involving mechanisms of glucose-stimulated insulin secretion and sensitivity, glucose uptake [48,58], beta cell apoptosis, and inflammation [59,60].”
Cutting Calories and TXNIP From the Skeletal Muscle to Restore Insulin Sensitivity
Anderson, E. J. (2015) · Diabetes · doi:10.2337/dbi15-0021 · Cited by 9
“A critical role for TXNIP in regulating glucose metabolism in humans was revealed in a report where TXNIP was shown to strongly inhibit glucose uptake, and this effect was abrogated by insulin (8).”
BackgroundStructural basis for a novel interaction between TXNIP and Vav2
Liu, S., Wu, X. F., Zong, M., Tempel, W., Loppnau, P., & Liu, Y. (2016) · FEBS Letters · doi:10.1002/1873-3468.12110 · Cited by 11
Ra, S., Kawamoto, E., Koshinaka, K., Iwabe, M., Tomiga, Y., Iizawa, H., Honda, H., Higaki, Y., & Kawanaka, K. (2020) · Physiological Reports · doi:10.14814/phy2.14388 · Cited by 9
“In addition, independent of its Trx-binding property, TXNIP was more recently shown to be a key negative regulator of glucose uptake in peripheral tissues in both an insulin-independent and an insulin-dependent manner (Hui et al., 2008; Parikh et al., 2007; Waldhart et al., 2017; Wu et al., 2013; Yoshihara et al., 201…”
BackgroundNorlin, S., Axelsson, J., Ericsson, M., & Edlund, H. (2023) · Communications Biology · doi:10.1038/s42003-023-05255-6 · Cited by 12
“Hypergly-cemia increases Thioredoxin-interacting protein (TXNIP) levels and elevated TXNIP levels are markers of glucotoxicity effects including reduced skeletal muscle and cardiac glucose uptake, diabetic cardiomyopathy, and impaired β -cell function 27 – 31 .”
Eren, E., Aykal, G., Sayrac, S., Erol, O. Ö., Elli̇dağ, H. Y., & Yılmaz, N. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2016.1163685 · Cited by 9
“Furthermore, a recent study of genome-wide expression profiles has indicated that the human TXNIP gene is important in regulating peripheral glucose metabolism [13].”
BackgroundInfluentialTissue Non-Specific Genes and Pathways Associated with Diabetes: An Expression Meta-Analysis
Mei, H., Li, L., Liu, S., Jiang, F., Griswold, M. E., & Mosley, T. H. (2017) · Genes · doi:10.3390/genes8010044 · Cited by 11
“2 GDS2790 GPL80 17472435 [30] 12,885 12 Before vs.”
Effect of Sleeve Gastrectomy on Plasma Thioredoxin-Interacting Protein (TXNIP)
Chu, Y., Widjaja, J., Hong, J., Dolo, P. R., Zhu, X., & Yao, L. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05649-7 · Cited by 9
“In the skeletal muscle of humans, TXNIP has been shown to regulate both insulin-dependent and -independent pathways of glucose uptake [26].”
BackgroundHong, X., Wu, Z., Cao, W., Lv, J., Yu, C., Huang, T., Sun, D., Liao, C., Pang, Y., Pang, Z., et al. (2022) · Diabetes · doi:10.2337/db22-0513 · Cited by 11
TXNIP overexpression in mice enhances streptozotocin-induced diabetes severity
Schneider, M. R., Zettler, S., Rathkolb, B., & Dahlhoff, M. (2023) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2023.111885 · Cited by 9
“Furthermore, in human skeletal muscle TXNIP is involved in insulin-dependent and independent regulatory mechanisms of glucose uptake and its deletion reduces the production of glucose in the liver (Chutkow et al., 2008; Parikh et al., 2007).”
BackgroundJung, S. Y., Bhatti, P., & Pellegrini, M. A. (2023) · Clinical Epigenetics · doi:10.1186/s13148-023-01435-7 · Cited by 10
“The TXNIP gene is activated in both hyperglycemic animals and human adipose tissues [69], and it regulates glucometabolic pathways in human skeletal muscle [70].”
BackgroundShah, A., Dağdeviren, S., Lewandowski, J. P., Schmider, A. B., Ricci-Blair, E. M., Natarajan, N., Hundal, H., Noh, H. L., Friedline, R. H., Vidoudez, C., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101521 · Cited by 12
Self-citationLiu, C., Zhu, T., Zhang, J., Wang, J., Gao, F., Ou, Q., Jin, C., Xu, J., Zhang, J., Tian, H., et al. (2021) · IUBMB Life · doi:10.1002/iub.2544 · Cited by 10
Kang, C. W., Nam, J. H., Oh, J. H., Wang, E. K., Lee, S. H., Shin, H. J., Kim, Y. B., Lee, E. J., Lim, B. K., Fang, S., et al. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01518-w · Cited by 10
Metabolic reprogramming in colorectal cancer: Mechanisms and therapeutic insights
Xiao, W., Tan, D., Zeng, W., Nie, X., & Wang, M. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102054 · Cited by 8
“211 Besides facilitating glucose import, Akt orchestrates vital glycolytic processes through the phosphorylation of specific catalysts.”
Triantafyllidou, P., Papadopoulou, A., Thymara, E., Papaevangelou, V., Mastorakos, G. P., Papadimitriou, A., Kalantaridou, S., Stratakis, C. A., & Alexopoulou, E. (2023) · Current Vascular Pharmacology · doi:10.2174/1570161121666230727150854 · Cited by 8
Wu, J., Zhang, Y., Li, J., Zhu, G., Bi, Z., & Li, X. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.11.027 · Cited by 8
What the BTBR/J mouse has taught us about diabetes and diabetic complications
Keller, M. P., Hudkins, K. L., Shalev, A., Bhatnagar, S., Kebede, M. A., Merrins, M. J., Davis, D. B., Alpers, C. E., Kimple, M. E., & Attie, A. (2023) · iScience · doi:10.1016/j.isci.2023.107036 · Cited by 8
“In addition, the double-mutant mice also showed some improvement in insulin sensitivity,(37) consistent with the downregulation of ubiquitously expressed Txnip in extra-pancreatic tissues and the reported effects of Txnip knockdown promoting glucose uptake in muscle and adipose tissue.(38,39)”
BackgroundTechnology Insight: small, noncoding RNA molecules as tools to study and treat endocrine diseases
Kolfschoten, I., & Regazzi, R. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0674 · Cited by 8
Loss of transketolase promotes the anti-diabetic role of brown adipose tissues
Ji, Y., Liu, W., Zhu, Y., Li, Y., Lu, Y., Liu, Q., Tong, L., Hu, L., Xu, N., Chen, Z., et al. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0047 · Cited by 7
Giovannini, S., Li, Y., Pecorari, R., Fierro, C., Fiorilli, C., Corigliano, F., Moriconi, V., Zhou, J. Y., Antoni, A. D., Smirnov, A., et al. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13722 · Cited by 8
Zhao, X., Zhang, Y., Li, X., Wang, R., & Jiao, X. (2014) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmu006 · Cited by 8
“This is consistent with other reports in many types of cells including cardiomyocytes [39], and even in human diabetes [40].”
ResultType 2 Diabetes, Immunity and Cardiovascular Risk: A Complex Relationship
Pedicino, D., Francesca, A., Alessandro, V., Trotta, F., & Liuzzo, G. (2012) · InTech eBooks · doi:10.5772/50611 · Cited by 7
“TXNIP expression is induced by glucose (Oka et al., 2009) and repressed by insulin (Parikh et al., 2007).”
BackgroundRegulation of G0/G1 switch gene 2 (G0S2) expression in human adipose tissue
Skopp, A., May, M., Janke, J., Kielstein, H., Wunder, R., Flade-Kuthe, R., Kuthe, A., Jordan, J., & Engeli, S. (2016) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2015.1122066 · Cited by 7
“Moreover, insulin stimulated G0S2 expression in skeletal muscle biopsies obtained from healthy adults (Parikh et al. 2007).”
BackgroundHao, Y., Shen, S., Yin, F., Zhang, Y., & Liu, J. (2019) · Cell Biochemistry and Function · doi:10.1002/cbf.3414 · Cited by 7
Parallel multiplicity and error discovery rate (EDR) in microarray experiments
Xu, W. W., & Carter, C. J. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-465 · Cited by 7
“This data set was reported in a study to examine the effects of insulin on gene expression in human health [21].”
BackgroundMethodInfluentialXu, H., Hutchinson, T. E., Koganti, S. R. K., Rousseau, B. A., Xia, D., McIntosh, M. T., & Bhaduri‐McIntosh, S. (2025) · NAR Cancer · doi:10.1093/narcan/zcaf017 · Cited by 9
“Furthermore, TXNIP’s involvement in glucose metabolism links it to metabolic con-6 ditions, such as diabetes, which are known to activate the NLRP3 inflammasome [ 29–31 ].”
TXNIP in cancer: Unlocking biological insights and tackling clinical challenges
Console, P. D., Gelsomino, L., Giordano, C., Pietramala, E., Bonofiglio, D., Andò, S., Catalano, S., & Barone, I. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189394 · Cited by 7
Hendawy, N., El-Sayed, S., Abdel-Wahed, D. M., Salaheldin, S. H., & Abuelezz, S. A. (2025) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgaf051 · Cited by 6
Redox regulation of HIV-1: the thioredoxin pathway, oxidative metabolism, and latency control
Mangold, J. F., & Swartz, T. H. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1651148 · Cited by 6
Ma, Q., Ren, J., Chen, L., Guo, W., Feng, K., Zhang, Y., Shen, W., Huang, T., & Cai, Y. (2026) · Cancer Genetics · doi:10.1016/j.cancergen.2026.01.003 · Cited by 6
Immunometabolic factors contributing to obesity-linked hepatocellular carcinoma
Akl, M. G., & Widenmaier, S. B. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1089124 · Cited by 9
“One mechanism is via suppressing thioredoxininteracting protein (TXNIP), which is a tumor suppressor that regulates glucose flux (Parikh et al., 2007; Katturajan et al., 2022).”
BackgroundWu, Y., Chen, W., Zhao, Y., Gu, M., Gao, Y., Ke, Y., Wang, L., Wang, M., Zhang, W., Chen, Y., et al. (2024) · Journal of Human Genetics · doi:10.1038/s10038-024-01243-8 · Cited by 6
“An elevated level of TXNIP has been reported in individuals with hypomethylation of the TXNIP gene, which can mediate the apoptosis of pancreatic β cells, and then result in hyperglycemia, ultimately progressing to T2DM [35, 36].”
Exploring the combined therapeutic efficacy of bexarotene and icariin in type 2 diabetic rats
Dik, B., Parlak, T. M., Ateş, M. B., & Tufan, Ö. (2024) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgae100 · Cited by 6
Turnbull, P. C., Ramos, S. V., MacPherson, R. E. K., Roy, B. D., & Peters, S. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120136 · Cited by 7
“[6], demonstrated that G0S2 mRNA expression rose significantly following a hyperinsulinemic euglycemic clamp (in vivo), demonstrating the acute responsiveness of the G0S2 gene to elevated insulin concentrations and increased muscle glucose uptake.”
Juvinao-Quintero, D. L., Cárdenas, A., Perron, P., Bouchard, L., Lutz, S. M., & Hivert, M. (2021) · Epigenomics · doi:10.2217/epi-2021-0220 · Cited by 6
Mogami, H., Yura, S., Tatsumi, K., Fujii, T., Fujita, K., Kakui, K., Kondoh, E., Inoue, T., Fujii, S., Yodoi, J., et al. (2010) · Pediatric Research · doi:10.1203/pdr.0b013e3181c2f4cc · Cited by 8
Roshanravan, N., Mahdavi, R., Jafarabadi, M. A., Alizadeh, E., Alipour, S., Ghavami, A., Alamdari, N. M., Hedayati, M., Barati, M., Mansoori, B., et al. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.07.019 · Cited by 7
Peng, Y.-C., Ye, Y.-S., Hu, Q.-X., Hao, Z.-Q., Li, Z., Jiang, L.-Y., Peng, H., Liu, R., Zha, Z.-G., & Zhang, H. (2025) · Arthritis Research & Therapy · doi:10.1186/s13075-025-03624-6 · Cited by 6
“Alternatively, altered Txnip expression may interfere with glucose metabolism in BMMs [32, 33], leading to insufficient energy supply required for osteoclast differentiation (Fig.”
Qihu Preparation Ameliorates Diabetes by Activating the AMPK Signaling Pathway in db/db Mice
Zeng, H., Li, X., Zhou, D., Wang, N., Yu, X., Long, L., Cheng, H., Zhou, S., Shen, Z., & Zhou, W. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s312137 · Cited by 5
Wang, Y., Liu, J., Liu, H., Sun, X., Chen, R., Liao, B., Zeng, X., Zhang, X., Dong, S., Xia, Z., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1064375 · Cited by 7
“This connection is of significant physiological relevance, owing to the finding that after its induction, TXNIP negatively regulates glucose uptake (18, 21, 22).”
BackgroundDeng, T., Cui, J., Lyon, C. J., Zhang, N., Wang, H. Y., Wang, R., & Hsueh, W. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6819-6_2 · Cited by 5
Dahab, M. M., Fu, B., Osman, E. E., Xu, Y., & Zhang, P. (2019) · Journal of Essential Oil Bearing Plants · doi:10.1080/0972060x.2019.1611485 · Cited by 6
Masoudi, M., Saghebjoo, M., Kazemi, T., & Hedayati, M. (2022) · Middle East Journal of Rehabilitation and Health Studies · doi:10.5812/mejrh-129041 · Cited by 4
“Therefore, it seems that participating in a regular and codified exercise program can play a major role in reducing TXNIP and improving insulin sensitivity (40).”
BackgroundCai, Y., & Chen, Q. (2024) · Phytotherapy Research · doi:10.1002/ptr.8416 · Cited by 4
“Supplementation with mixed polyphenols decreases the expression of thioredoxin-interacting protein, which regulates pancreatic β-cell insulin secretion, in overweight patients and those with obesity (Jo et al. 2013; Parikh et al. 2007; Xu, Chen, et al. 2013).”
Oral TIX100 protects against obesity‐associated glucose intolerance and diet‐induced adiposity
Jo, S., Gu, J., Chen, J., Xu, G., & Shalev, A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16223 · Cited by 5
Tu, Y., Zhang, P., & Pang, X. (2015) · Cancer translational medicine · doi:10.4103/2395-3977.151488 · Cited by 5
Adenine derivatives invert high glucose‐induced thioredoxin‐interacting protein overexpression
Li, Z., Liu, Q., Ting, Y. S., Thien, V. Y., Kalong, N. S. B., Yang, D., & Wang, M. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13371 · Cited by 4
Metadata
- Authors
- Parikh, H., Carlsson, E., Chutkow, W. A., Johansson, L. E., Storgaard, H., Poulsen, P., Saxena, R., Ladd, C., Schulze, P. C., Mazzini, M. J., Jensen, C. B., Krook, A., Björnholm, M., Tornqvist, H., Zierath, J. R., Ridderstråle, M., Altshuler, D., Lee, R. T., Vaag, A., Groop, L. C., & Mootha, V. K.
- Affiliations
- Lund University (SE)
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- Karolinska Institutet (SE)
- Novo Nordisk (Denmark) (DK)
- University of Helsinki (FI)
- Corresponding author
- Groop, Leif C
- Mootha, Vamsi K
- ORCID
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-05-01
- Volume
- 4
- Issue
- 5
- Pages
- e158
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC1858708
- OpenAlex
- W2158951820
- Cited by
- 495
- References
- 57
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 24 · 2023: 41 · 2022: 35 · 2021: 39 · 2020: 34 · 2019: 22 · 2018: 29 · 2017: 21 · 2016: 29 · 2015: 29 · 2014: 23 · 2013: 28 · 2012: 31
- FWCI
- 8.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- American Diabetes Association
- Burroughs Wellcome Fund
- Richard and Susan Smith Family Foundation
- European Commission
- Karolinska Institutet
- Novo Nordisk
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- TXNIP, type 2 diabetes, skeletal muscle glucose uptake, peripheral glucose metabolism, insulin signaling, adipocytes, prediabetes, glucose homeostasis, insulin-independent glucose uptake, genetic association
- MeSH terms
- Animals, Blood Glucose, Carrier Proteins, Cells, Cultured, Diabetes Mellitus, Type 2, DNA-Binding Proteins, Gene Expression Regulation, Homeostasis, Humans, Hypoglycemic Agents, Insulin, Promoter Regions, Genetic, Glucose Clamp Technique, Linkage Disequilibrium, Polymerase Chain Reaction, Adipocytes, Glucose Intolerance, Muscle, Skeletal, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Protein Array Analysis, Qb-SNARE Proteins, Proto-Oncogene Proteins c-bcl-6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.